In addition, some researchers[8] supposed that determination of the association between the CT-based radiomic features and the EGFR mutation status could provide a useful clinical predictor in patients with unresectable lung cancer or in whom biopsy was unacceptable. The gene discussed is EGFR; the disease is lung cancer.